This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Dec 1;181(12):1560.

doi: 10.1001/jamainternmed.2021.5634.

COVID-19 Messenger RNA Vaccination and Myocarditis-A Rare and Mostly Mild Adverse Effect

Vinay Guduguntla^{1

2}, Mitchell H Katz^{3

4}

Affiliations

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Editorial Fellow, JAMA Internal Medicine.
³ NYC Health + Hospitals, New York, New York.
⁴ Deputy Editor, JAMA Internal Medicine.

PMID: 34605851
DOI: 10.1001/jamainternmed.2021.5634

Editorial

COVID-19 Messenger RNA Vaccination and Myocarditis-A Rare and Mostly Mild Adverse Effect

Vinay Guduguntla et al. JAMA Intern Med. 2021.

. 2021 Dec 1;181(12):1560.

doi: 10.1001/jamainternmed.2021.5634.

Authors

Vinay Guduguntla^{1

2}, Mitchell H Katz^{3

4}

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Editorial Fellow, JAMA Internal Medicine.
³ NYC Health + Hospitals, New York, New York.
⁴ Deputy Editor, JAMA Internal Medicine.

PMID: 34605851
DOI: 10.1001/jamainternmed.2021.5634

No abstract available

PubMed Disclaimer

Comment on

Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
Simone A, Herald J, Chen A, Gulati N, Shen AY, Lewin B, Lee MS. Simone A, et al. JAMA Intern Med. 2021 Dec 1;181(12):1668-1670. doi: 10.1001/jamainternmed.2021.5511. JAMA Intern Med. 2021. PMID: 34605853 Free PMC article.

Similar articles

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series.
Murakami Y, Shinohara M, Oka Y, Wada R, Noike R, Ohara H, Fujino T, Ikeda T. Murakami Y, et al. Intern Med. 2022 Feb 15;61(4):501-505. doi: 10.2169/internalmedicine.8731-21. Epub 2021 Nov 27. Intern Med. 2022. PMID: 34840235 Free PMC article.
Myopericarditis After COVID-19 mRNA Vaccination.
Sakaguchi S, Fujimoto N, Ichikawa K, Izumi D, Katsuta K, Takafuji M, Imanaka-Yoshida K, Dohi K. Sakaguchi S, et al. Circ J. 2022 Feb 25;86(3):472. doi: 10.1253/circj.CJ-21-0683. Epub 2021 Sep 30. Circ J. 2022. PMID: 34588400 No abstract available.
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination.
Hansbauer M, Fastantz E, Lutz J, Hasan A. Hansbauer M, et al. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):502-503. doi: 10.1097/JCP.0000000000001577. Epub 2022 Aug 2. J Clin Psychopharmacol. 2022. PMID: 35916561 No abstract available.
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
Haaf P, Kuster GM, Mueller C, Berger CT, Monney P, Burger P, Stämpfli SF, Attenhofer Jost CH, Zellweger MJ, Osswald S, Donner BC, Koestner SC, Tanner FC. Haaf P, et al. Swiss Med Wkly. 2021 Oct 19;151:w30087. doi: 10.4414/smw.2021.w30087. eCollection 2021 Oct 11. Swiss Med Wkly. 2021. PMID: 34668687 Review.
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB. Lui DTW, et al. Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021. Front Public Health. 2021. PMID: 34888290 Free PMC article. Review.

See all similar articles

Cited by

Two Cases of Acute Myocarditis in Young Male Adults After mRNA Vaccines Against COVID-19: Similarities and Differences.
Sdogkos E, Sideri A, Kasmeridis C, Konstantinou T, Vogiatzis I. Sdogkos E, et al. Med Arch. 2022 Jun;76(3):215-220. doi: 10.5455/medarh.2022.76.215-220. Med Arch. 2022. PMID: 36200112 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information